Elixir Remedies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-05-2024
- Paid Up Capital ₹ 0.10 M
as on 19-05-2024
- Company Age 9 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Revenue 88.19%
(FY 2020)
- Profit -21.60%
(FY 2020)
- Ebitda -9.13%
(FY 2020)
- Net Worth -91.52%
(FY 2020)
- Total Assets 36.83%
(FY 2020)
About Elixir Remedies
The Company is engaged in the Pharmaceuticals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jasmin Shah, Beenaben Patel, Jigneshkumar Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2015PTC084299
- Company No.
084299
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Elixir Remedies?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jigneshkumar Patel  | Director | 14-Feb-2018 | Current |
| Jasmin Shah | Director | 15-Sep-2022 | Current |
| Beenaben Patel | Director | 22-Jul-2019 | Current |
| Laljibhai Gohel | Director | 15-Sep-2022 | Current |
| Ashvinkumar Patel | Director | 15-Sep-2022 | Current |
Financial Performance and Corporate Structure Insights of Elixir Remedies.
Elixir Remedies Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 88.19% increase. The company also saw a substantial fall in profitability, with a 21.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 91.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elixir Remedies?
In 2018, Elixir Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Elixir Pharma Chem Private Limited
Active
1 year 2 months Beenaben Patel and Jigneshkumar Patel are mutual person
Biosphere Hospitality Llp
Active 1 year 6 months Jasmin Shah, Jigneshkumar Patel and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Elixir Remedies?
Unlock and access historical data on people associated with Elixir Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elixir Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elixir Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
